Relevance of alloimmunization in haemolytic transfusion reaction in sickle cell disease

Transfusion Clinique et Biologique

Volumn 19, Issue 3, 2012, Pages 132-138

  Noizat Pirenne, F ^a  

^a HENRI MONDOR HOSPITAL   (France)

Author keywords

Alloimmunization; Autoantibodies; Haemolysis; Partial RH; Sickle cell disease; Transfusion

Indexed keywords

AUTOANTIBODY; FC RECEPTOR; IMMUNOGLOBULIN; IMMUNOGLOBULIN G3;

AFRICAN; ALLOIMMUNIZATION; ANTIBODY DETECTION; ANTIBODY TITER; ANTIGEN EXPRESSION; ARTICLE; AUTOIMMUNE HEMOLYTIC ANEMIA; BLOOD DONOR; BLOOD GROUP ABO SYSTEM; BLOOD GROUP RH; BLOOD GROUP TYPING; BLOOD TRANSFUSION; BLOOD TRANSFUSION REACTION; DISEASE SEVERITY; ETHNICITY; HEMOLYSIS; HUMAN; IMMUNOGENICITY; IRON OVERLOAD; NONHUMAN; OXIDATIVE STRESS; PHENOTYPE; RISK FACTOR; SICKLE CELL ANEMIA;

ANEMIA, SICKLE CELL; AUTOIMMUNE DISEASES; BLOOD GROUP INCOMPATIBILITY; BLOOD TRANSFUSION; HEMOLYSIS; HUMANS; ISOANTIBODIES;

EID: 84864754477     PISSN: 12467820     EISSN: 19538022     Source Type: Journal    
DOI: 10.1016/j.tracli.2012.03.004     Document Type: Article

References (42)

1. Adams R.J., Brambilla D. Discontinuing prophylactic transfusions used to prevent stroke in sickle cell disease. N Engl J Med 2005, 353:2769-2778.
2. Vichinsky E.P. Current issues with blood transfusions in sickle cell disease. Semin Hematol 2001, 38:14-22.
3. Natukunda B., Schonewille H., van de Watering L., Brand A. Prevalence and specificities of red blood cell alloantibodies in transfused Ugandans with different diseases. Vox Sang 2010, 98:167-171.
4. Olujohungbe A., Hambleton I., Stephens L., Serjeant B., Serjeant G. Red cell antibodies in patients with homozygous sickle cell disease: a comparison of patients in Jamaica and the United Kingdom. Br J Haematol 2001, 113:661-665.
5. Natukunda B., Brand A., Schonewille H. Red blood cell alloimmunization from an African perspective. Curr Opin Hematol 2010, 17:565-570.
6. Lasalle-Williams M., Nuss R., Le T., Cole L., Hassell K., Murphy, et al. Extended red blood cell antigen matching for transfusions in sickle cell disease: a review of a 14-year experience from a single center (CME). Transfusion 2011, 51:1732-1739.
7. Meunier N., Rodet M., Bonin P., Chadebech P., Chami B., Lee K., Habibi A., Bachir D., Galacteros F., Bierling P., Noizat-Pirenne F. étude d'une cohorte de 206 patients drépanocytaires adultes transfusés: immunisation, risque transfusionnel et ressources en concentrés globulaires. Transfus Clin Biol 2008, 15:377-382.
8. Zimring J.C., Hendrickson J.E. The role of inflammation in alloimmunization to antigens on transfused red blood cells. Curr Opin Hematol 2008, 15:631-635.
9. Young P.P., Uzieblo A., Trulock E., Lublin D.M., Goodnough L.T. Autoantibody formation after alloimmunization: are blood transfusions a risk factor for autoimmune hemolytic anemia?. Transfusion 2004, 44:67-72.
10. Aygun B., Padmanabhan S., Paley C., Chandrasekaran V. Clinical significance of RBC alloantibodies and autoantibodies in sickle cell patients who received transfusions. Transfusion 2002, 42:37-43.
11. Noizat-Pirenne F., Bachir D., Chadebech P., Michel M., Plonquet A., Lecron J.C., Galacteros F., Bierling P. Rituximab for prevention of delayed hemolytic transfusion reaction in sickle cell disease. Haematologica 2007, 92:e132-e135.
12. Chadebech P., Habibi A., Nzouakou R., Bachir D., Meunier-Costes N., Bonin P., Rodet M., Chami B., Galacteros F., Bierling P., Noizat-Pirenne F. Delayed hemolytic transfusion reaction in sickle cell disease patients: evidence of an emerging syndrome with suicidal red blood cell death. Transfusion 2009, 49:1785-1792.
13. Mqadmi A., Zheng X., Yazdanbakhsh K. CD4+CD25+ regulatory T cells control induction of autoimmune hemolytic anemia. Blood 2005, 105:3746-3748.
14. Zimring J.C., Spitalnik S.L., Roback J.D., Hillyer C.D. Transfusion-induced autoantibodies and differential immunogenicity of blood group antigens: a novel hypothesis. Transfusion 2007, 47:2189-2196.
15. Castellino S.M., Combs M.R., Zimmerman S.A., Issitt P.D., Ware R.E. Erythrocyte autoantibodies in paediatric patients with sickle cell disease receiving transfusion therapy: frequency, characteristics and significance. Br J Haematol 1999, 104:189-194.
16. Liu Y., Masuda E., Blank M.C., Kirou K.A., Gao X., Park M.S., Pricop L. Cytokine-mediated regulation of activating and inhibitory Fc gamma receptors in human monocytes. J Leukoc Biol 2005, 77:767-776.
17. Styles L.A., Schalkwijk C.G., Aarsman A.J., Vichinsky E.P., Lubin B.H., Kuypers F.A. Phospholipase A2 levels in acute chest syndrome of sickle cell disease. Blood 1996, 87:2573-2578.
18. Jang J.E., Hod E.A., Spitalnik S.L., Frenette P.S. CXCL1 and its receptor, CXCR2, mediate murine sickle cell vaso-occlusion during hemolytic transfusion reactions. J Clin Invest 2011, 121:1397-1401.
19. Closse C., Dachary-Prigent J., Boisseau M.R. Phosphatidylserine-related adhesion of human erythrocytes to vascular endothelium. Br J Haematol 1999, 107:300-302.
20. de Montalembert M., Dumont M.D., Heilbronner C., Brousse V., Charrara O., Pellegrino B., Piguet C., Soussan V., Noizat-Pirenne F. Delayed hemolytic transfusion reaction in children with sickle cell disease. Haematologica 2011, 96:801-807.
21. Win N., Sinha S., Lee E., Mills W. Treatment with intravenous immunoglobuline and steroids may correct severe anemia in hyper-hemolytic transfusion reactions: case report and literature review. Transfus Med Rev 2010, 24:64-67.
22. Islam M.S., Chia L. Hyperhemolysis syndrome in a patient with sickle cell disease with erythrophagocytosis in peripheral blood. Eur J Haematol 2009, 84:188.
23. Elenga N., Mialou V., Kebaili K., Galambrun C., Bertrand Y., Pondarre C. Severe neurologic complication after delayed haemolytic transfusion reaction in 2 children with sickle cell anemia. J Pediatr Hematol Oncol. 2008, 30:928-930.
24. Win N., New H., Lee E., de la Fuente J. Hyperhemolysis syndrome in sickle cell disease: case report (recurrent episode) and literature review. Transfusion 2008, 48:1231-1238.
25. Proudfit C.L., Atta E., Doyle N.M. Hemolytic transfusion reaction after preoperative prophylactic blood transfusion for sickle cell disease in pregnancy. Obstet Gynecol 2007, 110:471-474.
26. McGlennan A.P., Grundy E.M. Delayed haemolytic transfusion reaction and hyperhaemolysis complicating peri-operative blood transfusion in sickle cell disease. Anaesthesia 2005, 60:609-612.
27. Talano J.A., Hillery C.A., Gottschall J.L., Baylerian D.M., Scott J.P. Delayed haemolytic transfusion reaction/hyperhemolysis syndrome in children with sickle cell disease. Pediatrics 2003, 111:e661-e665.
28. Noizat-Pirenne F., Lee K., Le Pennec P.Y., Simon P., Kazup P., Bachir D., et al. Rare RHCE phenotypes in black individuals of Afro-Caribbean origin: identification and transfusion safety. Blood. 2002, 100:4223-4231.
29. Win N., Doughty H., Telfer P., Wild B.J., Pearson T.C. Hyperhemolytic transfusion reaction in sickle cell disease. Transfusion 2001, 41:323-328.
30. Fabron A., Moreira G., Bordin J.O. Delayed hemolytic transfusion reaction presenting as a painful crisis in a patient with sickle cell anemia. Sao Paulo Med J 1999, 117:38-39.
31. Kalyanaraman M., Heidemann S.M., Sarnaik A.P., Meert K.L., Sarnaik S.A. Anti-s antibody-associated delayed hemolytic transfusion reaction in patients with sickle cell anemia. J Pediatr Hematol Oncol 1999, 21:70-73.
32. Anderson R.R., Sosler S.D., Kovach J., De Christopher P.J. Delayed hemolytic transfusion reaction due to anti-Js(a) in an alloimmunized patient with a sickle cell syndrome. Am J Clin Pathol 1997, 108:658-661.
33. King K.E., Shirey R.S., Lankiewicz M.W., Young-Ramsaran J., Ness P.M. Delayed hemolytic transfusion reactions in sickle cell disease: simultaneous destruction of recipients' red cells. Transfusion 1997, 37:376-381.
34. Larson P.J., Lukas M.B., Friedman D.F., Manno C.S. Delayed hemolytic transfusion reaction due to anti-Go(a), an antibody against the low-prevalence Gonzales antigen. Am J Hematol 1996, 53:248-250.
35. Syed S.K., Sears D.A., Werch J.B., Udden M.M., Milam J.D. Case reports: delayed hemolytic transfusion reaction in sickle cell disease. Am J Med Sci 1996, 312:175-181.
36. Thornton J.B., Sams D.R. Preanesthesia transfusion and sickle cell anemia patients: case report and controversies. Spec Care Dentist 1993, 13:254-257.
37. Bowen D.T., Devenish A., Dalton J., Hewitt P.E. Delayed haemolytic transfusion reaction due to simultaneous appearance of anti-Fya and anti-Fy5. Vox Sang 1988, 55:35-36.
38. Cox J.V., Steane E., Cunningham G., Frenkel E.P. Risk of alloimmunization and delayed haemolytic transfusions reactions in patients with sickle cell disease. Arch Intern Med 1988, 148:2485-2489.
39. Rao K.R., Patel A.R. Delayed hemolytic transfusion reactions in sickle cell anemia. South Med J 1989, 82:1034-1036.
40. Milner P.F., Squires J.E., Larison P.J., Charles W.T., Krauss J.S. Posttransfusion crises in sickle cell anemia: role of delayed hemolytic reactions to transfusion. South Med J 1985, 78:1462-1469.
41. Squires J.E., Larison P.J., Charles W.T., Milner P.F. A delayed hemolytic transfusion reaction due to anti-Cob. Transfusion 1985, 25:137-139.
42. Brumfield C.G., Huddleston J.F., DuBois L.B., Harris B.A. A delayed hemolytic transfusion reaction after partial exchange transfusion for sickle cell disease in pregnancy: a case report and review of the literature. Obstet Gynecol 1984, 63:13S-15S.